Get the Stockscreener App
0.55
1.83%
0.0099
Ainos Inc stock is traded at $0.55, with a volume of 88,914.
It is up +1.83% in the last 24 hours and up +5.31% over the past month.
Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.
See More
Previous Close:
$0.5401
Open:
$0.54
24h Volume:
88,914
Relative Volume:
0.33
Market Cap:
$8.92M
Revenue:
$93,700
Net Income/Loss:
$-16.13M
P/E Ratio:
-0.1964
EPS:
-2.8
Net Cash Flow:
$-6.32M
1W Performance:
+5.77%
1M Performance:
+5.31%
6M Performance:
+0.47%
1Y Performance:
-47.12%
1-Day Range:
$0.53
$0.5644
1-Week Range:
$0.51
$0.65
52-Week Range:
$0.40
$1.46
Ainos Inc Stock (AIMD) Company Profile
Name
Ainos Inc
Sector
Industry
Phone
858-869-2986
Address
AINOS, INC., SAN DIEGO
Compare AIMD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AIMD
Ainos Inc
|
0.55 | 8.92M | 93,700 | -16.13M | -6.32M | -2.80 |
|
ABT
Abbott Laboratories
|
130.98 | 221.92B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
95.12 | 139.43B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
346.50 | 134.90B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
82.60 | 108.02B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
71.53 | 40.93B | 5.72B | 4.17B | 259.90M | 6.97 |
Ainos Inc Stock (AIMD) Latest News
Ainos, Inc. (NASDAQ:AIMD) Short Interest Update - Defense World
Ainos secures TFDA approval, IRB clearance to advance VELDONA trials - TipRanks
Major Breakthrough: Ainos Secures Two Key Approvals for $3.3B Market Drug Trials - Stock Titan
Groundbreaking AI Smell Technology Achieves 90% Accuracy, Targets Robotics Revolution - Stock Titan
Short Interest in Ainos, Inc. (NASDAQ:AIMD) Expands By 69.5% - Defense World
Ainos (OTCMKTS:AIMD) Shares Down 1.9% – Time to Sell? - Defense World
Revolutionary AI Nose Technology: How Ainos is Digitizing Smell for Smart Manufacturing - Stock Titan
Ainos, Inc. Reports 2024 Financial Results and Strategic Shift - MSN
Short Interest in Ainos, Inc. (NASDAQ:AIMD) Drops By 49.4% - The AM Reporter
Ainos, ASE team up to boost AI scent digitization - evertiq.com
Ainos, Inc. (NASDAQ:AIMD) Short Interest Down 49.4% in February - Defense World
Major Breakthrough: Ainos AI Nose Technology Lands Massive Deal with Semiconductor Giant ASE - StockTitan
Ainos, Inc: ASE Collaboration Expands AI Nose Opportunity in Smart Manufacturing - Smartkarma
Ainos and ASE partner for AI-driven air quality in chip-making - Investing.com Australia
Ainos and ASE Partner to Power AI Scent Digitization in Semicond - GuruFocus.com
Ainos, ASE to Use AI Nose Technology in Semiconductor Manufacturing -March 11, 2025 at 11:23 am EDT - Marketscreener.com
Ainos and ASE partner for AI-driven air quality in chip-making By Investing.com - Investing.com South Africa
Ainos and ASE Partner to Power AI Scent Digitization in Semiconductor Manufacturing - ACCESS Newswire
Revolutionary AI Nose Technology Transforms Semiconductor Manufacturing: Ainos and ASE Join Forces - Stock Titan
Ainos, IncPartners AI Nose to Give Robots the Ability to Smell - Smartkarma
Ainos Full Year 2024 Earnings: US$1.56 loss per share (vs US$3.36 loss in FY 2023) - Yahoo Finance
Ainos and ugo develop service robots with a sense of smell - Robot Report
Ainos Reports Full Year 2024 Financial Results - Financial Content
Can Robots Really Smell? This AI Partnership Just Made It Possible - StockTitan
AIMDAinos Inc Latest Stock News & Market Updates - StockTitan
Ainos and ugo to Develop the World's First Robot With a Sense of Smell - News Channel Nebraska
Ainos and ugo partner on scent-detecting robots By Investing.com - Investing.com Canada
Ainos And Ugo To Develop The World's First Robot With A Sense Of Smell - Barchart
Ainos and ugo partner on scent-detecting robots - Investing.com India
Pre-market Movers: ISPC, TH, IVVD, TOVX... - RTTNews
Violich Capital Management Inc. Acquires 1,395 Shares of Alphabet Inc. (NASDAQ:GOOGL) - Defense World
Ainos (OTCMKTS:AIMD) Shares Up 8.6% – Time to Buy? - Defense World
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.18% - MSN
Ainos Achieves Major Breakthrough: Japan Patent Approval for VELDONA Redefines Antiviral Innovation - NEWSnet
Ainos Secures Crucial Japanese Patent for Revolutionary Oral COVID Treatment VELDONA - StockTitan
Ainos unveils AI Nose for robotics - Today's Medical Developments
Ainos (OTCMKTS:AIMD) Shares Up 19% – Here’s What Happened - Defense World
Ainos AI Nose Technology Achieves 94% Accuracy in Health Diagnostics, Expands into Robotics - StockTitan
Ainos granted 180-day extension to regain Nasdaq compliance - TipRanks
Ainos Receives 180-Day Nasdaq Extension to Meet $1 Minimum Bid Requirement - StockTitan
Ainos Granted 180-Day Extension by Nasdaq to Regain Compliance With Minimum Bid Price Rule - The Globe and Mail
Ainos unveils ‘AI nose’ for robotics - Robotics and Automation News
Ainos Unveils AI Nose for Robotics: Invites Global Robotics Companies to Join Forces in Shaping the Future of Smell-Enabled Robots - AccessWire
Stock market today: IGM Biosciences plunged by 69.52% while XTI Aerospace down by 52.08% in early trading - Business Upturn
Pre-market Movers: CDT, NARI, GDTC, NARI... - RTTNews
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Wall Street Today: US stocks open higher amid AI optimism; S&P and Nasdaq Composite gains over 1% | Stock Market News - Mint
Short Interest in Ainos, Inc. (NASDAQ:AIMD) Grows By 58.1% - Defense World
Ainos Inc Stock (AIMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.01%
0.46%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):